Friday, July 24 Company Presentations 5–Diagnostics, Device, NPO
Name /mProbe Inc(台灣雲檢)
Address /7F., NO.398, XINGSHAN RD., NEIHU DIST., TAIPEI CITY 11469, TAIWAN
Name /Karl Sylvester
Title /Chief Medical Officer
With multi-omics as the critical evidence, mProbe has endeavored to interpret that evidence against a proprietary, vast clinically annotated, library of phenotypes using artificial intelligence.
In the same way the Human Genome Project scientists came together to catalog how a specific segment related to a specific genetic expression, we are cataloging how protein and metabolite expression relates to a disease, risk of a disease, progression of a disease and response to an intervention. The availability and application of artificial intelligence and advanced data science now make it possible for us to recognize those patterns using mass spectrometry on blood samples.
The results are foundational for truly personalized health and precision medicine.
Liquid Health CheckTM is a simple blood test giving providers, plans, employers or individuals insight into disease risk for avoidable conditions like hypertension, heart disease, diabetes, and kidney disease. The comprehensive Clinical Risk Report produced in our CAP/CLIA certified laboratory provides absolute and relative risk along with predicted time to the disease event for both high and low risk cohorts.
Liquid Health BaselineTM is a phenotypical analysis for providers, plans, employers or individuals informing a comprehensive risk profile for high impact disease and events like cancers, heart disease, diabetes, preeclampsia and pre-term birth.
Name /Max Su